CYP2B6 GENOTYPE AFFECTS METHADONE DISPOSITION IN CHILDREN AS DEMONSTRATED BY PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING.

被引：0
|
作者：
Gerhart, J. [1 ]
Edginton, A. [2 ]
Watt, K. [3 ]
Cohen-Wolkowiez, M. [3 ]
Harper, B. [3 ]
Muller, W. [4 ]
Delmore, P. [5 ]
Atz, A. [6 ]
Payne, E. [7 ]
Erinjeri, J. [7 ]
Lin, S. [7 ]
Gonzalez, D. [1 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] Univ Waterloo, Kitchener, ON, Canada
[3] Duke Clin Res Inst, Durham, NC USA
[4] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA
[5] Wesley Med Ctr, Wichita, KS USA
[6] Med Univ South Carolina, Charleston, SC 29425 USA
[7] Emmes, Rockville, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-106
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [21] PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING FOR PREDICTING TRANSPORTER-MEDIATED DRUG DISPOSITION IN HUMANS
    Watanabe, Takao
    Kusuhara, Hiroyuki
    Maeda, Kazuya
    Shitara, Yoshihisa
    Sugiyama, Yuichi
    DRUG METABOLISM REVIEWS, 2007, 39 : 98 - 98
  • [22] CYP2B6*6 Genotype Specific Differences in Artemether-Lumefantrine Disposition in Healthy Volunteers
    Abdullahi, Sa'ad T.
    Soyinka, Julius O.
    Olagunju, Adeniyi
    Bolarinwa, Rahman A.
    Olarewaju, Olusola J.
    Bakare-Odunola, Moji T.
    Winterberg, Markus
    Tarning, Joel
    Owen, Andrew
    Khoo, Saye
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (03): : 351 - 360
  • [23] Dosage Appropriacy Evaluation of Oral Venlafaxine Related to CYP2D6 Genotype Using Physiologically Based Pharmacokinetic (PBPK) Model
    Cho, Changkeun
    FASEB JOURNAL, 2020, 34
  • [24] A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4
    Lu Gaohua
    Abduljalil, Khaled
    Jamei, Masoud
    Johnson, Trevor N.
    Rostami-Hodjegan, Amin
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (05) : 873 - 885
  • [25] Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug-Drug-Gene Interaction Predictions
    Loer, Helena Leonie Hanae
    Tuerk, Denise
    Gomez-Mantilla, Jose David
    Selzer, Dominik
    Lehr, Thorsten
    PHARMACEUTICS, 2022, 14 (05)
  • [26] Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict Desloratadine Pharmacokinetics in Children
    Zhou, W.
    Johnson, T.
    Bui, K.
    Cheung, S. Y. A.
    Li, J.
    Xu, H.
    Al-Huniti, N.
    Zhou, D.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S138 - S138
  • [27] Physiologically based pharmacokinetic modeling (PBPK) for gaboxadol exposure in children with Angelman syndrome
    Gollen, Rakesh
    Parry, Tom
    Rakhit, Amit
    Graham, Martin
    NEUROLOGY, 2020, 94 (15)
  • [28] APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING TO PREDICT ONDANSETRON PHARMACOKINETICS IN CHILDREN
    Zhou, W.
    Johnson, T.
    Bui, K.
    Cheung, A.
    Li, J.
    Xu, H.
    Al-Huniti, N.
    Zhou, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S94 - S95
  • [29] Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism
    Cho, Chang-Keun
    Kang, Pureum
    Park, Hye-Jung
    Ko, Eunvin
    Mu, Chou Yen
    Lee, Yun Jeong
    Choi, Chang-Ik
    Kim, Hyung Sik
    Jang, Choon-Gon
    Bae, Jung-Woo
    Lee, Seok-Yong
    ARCHIVES OF PHARMACAL RESEARCH, 2022, 45 (05) : 352 - 366
  • [30] Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug-Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach
    Fuhr, Laura Maria
    Marok, Fatima Zahra
    Hanke, Nina
    Selzer, Dominik
    Lehr, Thorsten
    PHARMACEUTICS, 2021, 13 (02) : 1 - 21
12345